Saturday, May 18, 2013
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Areas
Cover Stories
Money for Nothing
Where is this new round of mergers and acquisitions coming from? Is the pharmaceutical industry in danger of consuming itself in its endless...
Building Relationships Around the Globe
Wyeth’s Joan Shen examines the benefits of choosing international locations for clinical trials.
The Freedom to Dream
Boehringer Ingelheim's Andreas Barner believes in allowing his researchers the space to follow their inspiration. The result has been three...
Vendor Perspectives
-
Becoming More Flexible
Why the pharmaceutical industry needs to evolve to meet its current challenges. By InnovexRead more -
Commercializing Options for Emerging Pha...
As large pharmaceutical companies continue to struggle with maximizing their ROI, emerging pharma companies’ attractive pipeline has provided them with many...Read more
Industry Analysts
-
Discovery Center
Tina Rogers, PhD, MBA, DABT, joined MPI Research as the Associate Director of Research in August 2007. Dr. Rogers brings a unique combination of scientific and business...Read more -
Innovation and Focus in Healthcare
Richard Vanderveer, Chief Executive Officer, GfK Healthcare, discusses a fundamental shift on the horizon, both in the practice of medicine and our approach to...Read more -
Improving Clinical Trial Efficiency and Ac...
Oncology clinical trials are expanding internationally while laboratory tests become increasingly complex. By Dr. Steven Potts, Worldwide Director, Biotech/Pharmaceutical,...Read more -
A View to the Future
New product development requires the close collaboration of virtually all functions inside a company. The existence of an effective cross-functional team, with clearly...Read more
Executive Interviews
Creating Business Advantages in the Biopharmace...
Mike Harrington of Waters Corporation looks at the company's unique approach to new technology development for an evolving industry.
Read more
Product Performance
TARP Worldwide explain the importance of physician interactions to improve product.
Read more
Making Discoveries
The specialized services needed to address pharmaceutical companies’ preclinical development needs.
Read more
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2013 GDS Publishing Ltd. All rights reserved.